Cargando...
An in vivo half-life extended prolactin receptor antagonist can prevent STAT5 phosphorylation
Increasing evidence suggests that signaling through the prolactin/prolactin receptor axis is important for stimulation the growth of many cancers including glioblastoma multiforme, breast and ovarian carcinoma. Efficient inhibitors of signaling have previously been developed but their applicability...
Gardado en:
| Publicado en: | PLoS One |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Public Library of Science
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6504076/ https://ncbi.nlm.nih.gov/pubmed/31063493 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0215831 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|